Pak1 in Mammary Gland Development and Carcinogenesis
Pak1 in Mammary Gland Development and Carcinogenesis
批准号:
6634035
负责人:
RAKESH KUMAR
金额:
$28.95万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-18 至 2005-04-30
关键词:
angiogenesis apoptosis breast neoplasms cell proliferation chemical carcinogenesis dimethylbenzanthracene enzyme activity enzyme induction /repression genetic susceptibility genetically modified animals laboratory mouse mammary gland metastasis neoplasm /cancer invasiveness neoplastic process protein kinase
中文摘要
描述:(扫描自申请人摘要)乳腺癌的能力
腺体发生肿瘤的能力受其正常发育的影响,
包括生殖活动。大量流行病学研究表明
系统内分泌模式和生殖变化发生在
人类乳房对乳腺癌具有重要意义。观察
同样的内分泌活动控制着乳房的发育,
乳腺癌的风险加强了乳腺发育的假设,
和肿瘤的发生有着根本的联系。通过以下方式了解机制
这些事件调节乳腺癌的发展将需要更好的方法
了解控制乳腺细胞增殖的基因,
转移蛋白激酶是已知的调节蛋白激酶活性的最大一类基因。
真核生物的生长、分化和发育。我们提出
为了研究p21激活激酶(Paki),
丝氨酸/苏氨酸激酶(在运动性,侵袭性,血管生成,
和细胞存活),对正常乳腺的发育,
与早期恶性和转移性乳腺癌有关的改变。
我们的工作假设是,功能性Pak 1通路是正常的
乳腺发育与Pak 1信号通路失调
在流感侵袭性疾病的发展和维持中起着重要作用,
通过支持细胞存活和血管生成来改善乳腺癌的表型。
提出这项建议的理由是基于联合国人权事务高级专员最近提出的意见。
主要研究者认为(i)Pak 1的表达控制运动,
乳腺癌细胞的侵袭性和非贴壁依赖性生长;(ii)Pak
1信号调节血管内皮生长因子的表达,
因此其功能;(iii)Pak 1激活支持细胞存活,
使促凋亡蛋白Bad失活;和(v)条件性表达促凋亡蛋白Bad,
在转基因小鼠模型中激酶死亡的巴基斯坦人导致发育不全,发育迟缓
乳腺导管内基质增强。这些发现
表明Pakl在正常乳腺发育中具有重要作用,
控制几种基本功能,包括细胞运动,
重塑、血管生成和细胞存活。因此,巴基斯坦的功能失调
pathwa 3可能构成乳腺癌发展的重要步骤。
本提案的具体目标是:(1)确定
显性阴性Pakl在转基因小鼠乳腺中的表达;
(2)确定组成性活跃的巴基斯坦人对乳腺的影响
(3)确定Pakl的共表达是否可以在转基因小鼠中表达;
影响HRG转基因小鼠乳腺肿瘤发生;和(4)确定
Pak 1功能对易感性的影响。我们独特的一面
建议是使用最近开发的Pak 1转基因小鼠获得新的
Paki作为正常乳腺癌关键信号通路的作用
腺体发育,也将允许主要研究者验证
病理生理学相关的先前组织培养结果
使用整个动物的实验设置。
英文摘要
DESCRIPTION: (Scanned from the applicant's abstract) The ability of the mammary
gland to undergo tumorigenesis is influenced by its normal development,
including reproductive events. Numerous epidemiological studies have suggested
that systemic endocrine patterns and reproductive changes occurring in the
human breast have important implications for breast cancer. The observation
that the same endocrine events control mammary development and influence
breast-cancer risk strengthens the hypothesis that mammary gland development
and tumorigenesis are fundamentally linked. Understanding the mechanisms by
which these events regulate breast cancer development will require a better
understanding of the genes that control mammary cell proliferation and
metastasis. Protein kinases are the largest class of genes known to regulate
growth, differentiation, and development in eukaryotic organisms. We propose
here to investigate the influence of p21-activated kinase (Paki), a
serine/threonine kinase (with roles in motility, invasiveness, angio genesis,
and cell survival), on the development of the normal mammary gland and
alterations involved in early malignant and metastatic breast cancer.
Our working hypotheses are that functional Pak1 pathway is required for normal
mammary gland development and that deregulation of the Pak1 signaling pathway
plays an essential role in the progression and maintenance of flu invasive
phenotype in breast cancer by supporting cell survival and angiogenesis.
The rationale for this proposal is based on observations recently made by the
Principal Investigator that (i) expression of Pak1 controls motility,
invasiveness and anchorage-independent growth of breast cancer cells; (ii) Pak
1 signaling regulates the expression of vascular endothelial growth factor and
consequently its function; (iii) Pak1 activation supports cell survival by
inactivating the proapoptotic protein Bad; and (v) conditional expression of a
kinase-dead Paki in a transgenic mouse model leads to hypoplasia, retardation
of ductal structures, and enhancement of intraductal stroma. These findings
suggest that Pakl has a significant role in normal mammary development by
controlling several essential functions, including cell motility and
remodeling, angiogenesis, and cell survival. Thus dysfunctions in the Pakl
pathwa3 may constitute an important step in breast cancer development.
The Specific Aims of this proposal are to: (1) determine the influence of
expression of dominant-negative Pakl in the mammary gland of transgenic mice;
(2) determine the influence of constitutively active Paki on mammary gland
biology in transgenic mice; (3) determine whether co-expression of Pakl can
influence mammary gland tumorigenesis in HRG transgenic mice; and (4) determine
the influence of Pak1 functions on the susceptibility. A unique aspect of our
proposal is the use of recently developed Pak1 transgenic mice to gain novel
insights about the role of Paki as critical signaling pathway in normal mammary
gland development, and will also allow the Principal Investigator to validate
the previous tissue culture findings in the pathophysiologically relevant
experimental setting by using whole animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SERM Regulation of PAK Pathway in Endometrial Cancer
-
批准号:7115811
-
项目类别:
-
资助金额:$30.23万
-
财政年份:2004
-
负责人:RAKESH KUMAR
-
依托单位:
SERM Regulation of PAK Pathway in Endometrial Cancer
-
批准号:6929343
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2004
-
负责人:RAKESH KUMAR
-
依托单位:
SERM Regulation of PAK Pathway in Endometrial Cancer
-
批准号:6815054
-
项目类别:
-
资助金额:$30.96万
-
财政年份:2004
-
负责人:RAKESH KUMAR
-
依托单位:
SERM Regulation of PAK Pathway in Endometrial Cancer
-
批准号:7228266
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2004
-
负责人:RAKESH KUMAR
-
依托单位:
Role of Metastatic Tumor Antigen-1 in Mammary Gland
-
批准号:6922026
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2003
-
负责人:RAKESH KUMAR
-
依托单位:
Role of Metastatic Tumor Antigen-1 in Mammary Gland
-
批准号:6770171
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2003
-
负责人:RAKESH KUMAR
-
依托单位:
Role of Metastatic Tumor Antigen-1 in Mammary Gland
-
批准号:7075426
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2003
-
负责人:RAKESH KUMAR
-
依托单位:
Role of Metastatic Tumor Antigen-1 in Mammary Gland
-
批准号:6682968
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2003
-
负责人:RAKESH KUMAR
-
依托单位:
Targeting Urokinase Pathway for Breast Cancer Therapy
-
批准号:6645655
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 in Mammary Gland Development and Carcinogenesis
-
批准号:6739038
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 in Mammary Gland Development and Carcinogenesis
-
批准号:6515030
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 and Hormone Response in Breast Cancer Progression
-
批准号:6984898
-
项目类别:
-
资助金额:$25.82万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Targeting Urokinase Pathway for Breast Cancer Therapy
-
批准号:6514790
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 in Mammary Gland Development and Carcinogenesis
-
批准号:6500017
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 in Mammary Gland Development and Carcinogenesis
-
批准号:6323974
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak 1 and Hormone Response in Breast Cancer Progression
-
批准号:7101009
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 and Hormone Response in Breast Cancer Progression
-
批准号:7212281
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Targeting Urokinase Pathway for Breast Cancer Therapy
-
批准号:6399863
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2001
-
负责人:RAKESH KUMAR
-
依托单位:
Pak1 - PIN Pathway in Breast Cancer Progression
-
批准号:6689147
-
项目类别:
-
资助金额:$27.18万
-
财政年份:1998
-
负责人:RAKESH KUMAR
-
依托单位:
HEREGULIN AND BREAST CANCER PROGRESSION
-
批准号:2742744
-
项目类别:
-
资助金额:$22.35万
-
财政年份:1998
-
负责人:RAKESH KUMAR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: